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• Chartis measurement of the lower lobes can be hampered by a “no-flow” phenomenon, preventing a 
reliable measurement of interlobar collateral ventilation.
• In the left lung, this can easily be resolved by performing measurement of the left major fissure in the 
left upper lobe.
• Measurement of the right major fissure in the right upper lobe is not directly possible because of the 
presence of the right middle lobe.
Novel Insights
• Temporary occlusion of the right middle lobe will facilitate a reliable Chartis measurement of the right 
major fissure in the right upper lobe.
• This occlusion can easily be performed using either a Watanabe spigot or a balloon catheter.
DOI: 10.1159/000507401
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Abstract
Background: Absence of interlobar collateral ventilation is 
essential to achieve lobar volume reduction after endobron-
chial valve (EBV) treatment and can be assessed using the 
Chartis measurement. However, especially in lower lobe 
measurements, Chartis can be complicated by the “no-flow 
phenomenon”, during which a sudden cessation of flow is 
observed, leading to an unreliable measurement. If this phe-
nomenon occurs in the right lower lobe, when measuring 
collateral flow over the right major fissure, the entrance to 
the right middle lobe should be occluded, and the Chartis 
balloon should be placed in the right upper lobe. Both Wata-
nabe spigots and balloon catheters can be used to achieve 
occlusion. Objective: Our aim was to demonstrate that right 
middle lobe occlusion with a blocking device is helpful in 
obtaining a reliable Chartis outcome in case of the no-flow 
phenomenon in the right lower lobe. Methods: We per-
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-





formed a retrospective analysis of patients scheduled for 
EBV treatment in an EBV registry between September 2016 
and September 2019. Results: We included 15 patients with 
severe emphysema (median age 63 years [range 47–73], 
73% female, and FEV1 24% [range 19–36] of predicted), who 
required temporary middle lobe occlusion (12 Watanabe 
spigot, 3 balloon catheter). After occlusion, a reliable Chartis 
outcome was obtained in all patients. Conclusion: Tempo-
rary middle lobe occlusion using a blocking device is helpful 
in obtaining a reliable Chartis outcome in case of a right low-
er lobe no-flow phenomenon. © 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
The absence of interlobar collateral ventilation is es-
sential to achieve lobar volume reduction with endobron-
chial valve (EBV) treatment in patients with severe em-
physema and can be assessed using the Chartis® (Pul-
monx, USA) measurement [1–4]. Chartis measurement 
can be complicated by the “no-flow phenomenon”, in 
which dynamic expiratory airway collapse is believed to 
cause a sudden cessation of flow during measurement, 
leading to an unreliable Chartis measurement [5]. Litera-
ture shows that this can occur in up to one-third of all 
measurements and most frequently affects the lower lobes 
[5–7]. Normally, Chartis measurement is performed in 
the lobe selected for treatment with EBV. When the no-
flow phenomenon occurs during measurement in the left 
lung, measurement in the adjacent lobe can easily be per-
formed to assess the integrity of the left major fissure [8]. 
However, in case of no flow in the right lower lobe, mea-
surement of the right upper lobe may not be reliable be-
cause collateral flow originating from the right middle 
lobe, due to common incompleteness of the right minor 
fissure, can result in false-positive Chartis outcomes [1]. 
If the middle lobe is not occluded, the measurement in the 
right upper lobe only measures the collateral flow over the 
right upper lobe fissure (part of the major fissure and mi-
nor fissure) and not the right major fissure.
Case Report
Methods
We performed a retrospective analysis in which we included all 
patients with the right lower lobe as primary EBV target and in 
which the no-flow phenomenon occurred during Chartis mea-
surement in the right lower lobe.
All patients were scheduled for treatment in the Dutch nation-
al EBV treatment registry (BREATH-NL) between September 
2016 and September 2019 (Clinicaltrials.gov identifier: 
NCT02815683). Chartis measurements were performed in all pa-
tients regardless of fissure integrity scores. The presence of collat-
eral ventilation was confirmed when a continuous, non-decreas-
ing, expiratory airway flow was observed during > 6 min or earlier 
with a similar pattern when totaling > 1 L [8]. Every patient under-
went Chartis measurement under general anesthesia using a previ-
ously described approach [9]. Target lobe volume and fissure in-
tegrity were assessed using the StratX quantitative CT Platform 
(Pulmonx).
To achieve the desired temporary occlusion of the right middle 
lobe, both Watanabe spigots® (Novatech, France) and Extractor® 
Pro retrieval balloon catheters (Boston Scientific, USA), were used. 
The Watanabe spigot (Fig. 1) is a silicon bronchial filler, which is 
frequently used for persistent pneumothorax, hemoptysis, and 
bronchopleural fistula, and is available in three sizes: 5, 6 and 7 mm 
in diameter [10]. The retrieval balloon (Fig. 2) can be inflated to 
any desired diameter between 5 and 20 mm and can be replaced 
by any locally available alternative balloon.
Our primary outcome was the success rate of right upper lobe 
Chartis measurement of the right major fissure after occlusion of 
the right middle lobe and placement of the Chartis balloon in the 
right upper lobe. Our secondary outcome was the amount of target 
lobe volume reduction after EBV treatment.
a b
Fig. 1. a Watanabe spigot. b Watanabe 
spigot held by a biopsy forceps, which can 
be used for both placement and removal of 
the spigot.
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A 63-year-old female with severe emphysema (forced expira-
tory volume in 1 s [FEV1] 25% of predicted and residual volume 
[RV] 214% of predicted) was scheduled for EBV treatment in 
our hospital. The predetermined target for treatment was the 
right lower lobe (51% of voxels <–950 Hounsfield Units). We 
were initially unable to obtain a reliable Chartis measurement in 
the right lower lobe, as we encountered the no-flow phenome-
non (Fig. 3a). After the occlusion of the right middle lobe with a 
Watanabe spigot, we performed a Chartis measurement in the 
right upper lobe, which indicated absence of interlobar collat-
eral ventilation of the right major fissure (Fig. 3b). Subsequent-
ly, five endobronchial valves were placed in the right lower lobe. 
Six weeks after treatment, the patient achieved a target lobe vol-
ume reduction of 1,201 mL, had an FEV1 of 40% of predicted 
(69% relative increase), and an RV of 148% of predicted (31% 
relative reduction).
a b
Fig. 2. a Watanabe spigot occluding the en-
trance of the right middle lobe. b Balloon 
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Fig. 3. a Chartis measurement output indicating the no-flow phe-
nomenon in the right lower lobe. The initially present flow be-
comes zero after the balloon seal is achieved, flow returns when the 
catheter is withdrawn with subsequent loss of the balloon seal, rul-
ing out other potential causes of no flow. b Chartis measurement 
output of the right upper lobe in the same patient, indicating ab-
sence of interlobar collateral ventilation after occlusion of the right 
middle lobe with a Watanabe spigot.
Table 1. Patient characteristics
Patients, n 15
Female/male, % 73/27
Age, years 63 (47–73)
BMI 22 (19–30)
Pack years 43 (10–85)
FEV1 predicted, % 24 (19–36)
RVpredicted, % 229 (187–317)
RV/TLC, ratio 0.65 (0.58–0.76)
6MWD, m 320 (15–484)
Data are presented as median (range), unless otherwise indi-
cated. BMI, body mass index; FEV1, forced expiratory volume in 







Out of the 220 EBV cases, 36 patients (16%) had the right low-
er lobe as primary target for EBV. In 15 out of these 36 cases (42%), 
we performed a temporary right middle lobe occlusion with either 
a Watanabe spigot or balloon catheter in order to perform Chartis 
measurement of the right major fissure.
Therefore, 15 patients were included in the analysis (73% fe-
male, median FEV1 24% of predicted) (baseline characteristics are 
presented in Table 1). Temporary right middle lobe occlusion was 
successful in all patients. The Watanabe spigot was used in 12 cas-
es. In 3 cases, the balloon catheter was used because the use of the 
Watanabe spigot was not possible because of a relatively large di-
ameter entrance to the right middle lobe.
In all patients a reliable Chartis measurement could be per-
formed after we placed the blocking device, and we did not observe 
a no-flow phenomenon. In 13 out of 15 patients (87%), the Chartis 
measurement in the right upper lobe indicated absence of collat-
eral ventilation of the right major fissure. Six weeks after treat-
ment, the median reduction in the target lobe volume was 863 mL, 
and 9 out of 13 patients (69%) had achieved the minimal important 
difference for target lobe volume reduction of 563 mL [11]. See 
Table 2 for Chartis measurement outcomes.
Discussion
This case series provides insight in the use of two differ-
ent approaches to temporary right middle lobe occlusion, 
Watanabe spigots and balloon catheters, to achieve reliable 
Chartis measurement outcomes. Using this technique, we 
were able to confirm the presence or absence of interlobar 
collateral ventilation of the right major fissure in all our pa-
tients after initial measurement of the right lower lobe had 
failed. We considered both the insertion and removal of the 
Watanabe spigot and balloon catheter very feasible (see 
www.karger.com/doi/10.1159/000507401 for online suppl. 
video). While not structurally assessed in this case series, 
use of the blocking devices did not prolong Chartis mea-
surement for more than several minutes. Although both 
blocking device approaches were feasible, in our practice, 
we generally reserve the use of a balloon catheter for pa-
tients with a relatively wide right middle lobe entrance, giv-
en its larger potential diameter (5–20 mm) than the Wata-
nabe spigot (5–7 mm).
While temporary right middle lobe occlusion was al-
ready recommended by the 2017 expert panel recommen-
dations on EBV treatment, to the best of our knowledge, no 
data has previously been published on this technique [8].
Before the absence of flow during Chartis measure-
ment is attributed to the no-flow phenomenon, we recom-
mend excluding other causes of absent flow: mucus im-
paction of the Chartis catheter should first be ruled out by 
flushing of the catheter, and in addition, correct catheter 
positioning should be verified. The catheter tip should not 
be in direct contact with the airway wall. While different 
terminology is used in the literature to describe the no-
flow phenomenon, for example “low flow” and “collapse 
phenomenon”, we suggest describing this problem as the 
no-flow phenomenon, as this description describes the 
clinical observation during measurement [5, 7].
Previous studies have attributed the no-flow phenome-
non to dynamic expiratory airway collapse, in which airway 
collapse distal to the inflated Chartis balloon prevents expi-
ratory airflow [5, 7]. While we consider this to be a valid 
explanation, the question remains why the lower lobes are 
more often affected by this phenomenon. A possible expla-
nation may be the transpulmonary pressure gradient from 
the apical zones to the basal zones in combination with the 
emphysematous lung tissue. More research is required to 
confirm the exact physiological mechanism causing this 
phenomenon and its lower-lobe predominance.
Table 2. Chartis measurement outcomes
Total EBV cases, n
Cases with RLL as primary EBV target, n









Chartis measurement outcome right major fissure (CV negative/CV positive), n 13/2
Target lobe volume at baseline, mL 1,625 (1,027 to 3,001)
Target lobe volume reduction at 6 weeks after treatment, mL –863 (–3,001 to 5)
Right major fissure integrity, % 99 (95 to 100)
Right minor fissure integrity, % 91 (58 to 98)
Data are presented as median (range), unless otherwise indicated. RLL, right lower lobe; RML, right middle 
lobe; EBV, endobronchial valve; CV, collateral ventilation.
Chartis Assessment of the Right Major 




In conclusion, selective temporary occlusion of the 
right middle lobe using a blocking device is helpful in ob-
taining a reliable Chartis outcome in case of the no-flow 
phenomenon in the right lower lobe. The application of 
this simple technique may improve patient selection and 
outcomes for EBV treatment.
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